About the Journal of Alzheimer’s Research and Therapy
- Open access · CC BY 4.0
- ISSN 2998-4211
- Published by Open Access Pub
The Journal of Alzheimer’s Research and Therapy (JALR) is a peer-reviewed, open-access journal of research on Alzheimer’s disease and related dementias, from mechanisms to therapy and care. It has been published by Open Access Pub since 2017.
Research along the disease continuum
JALR serves researchers, clinicians, care professionals and health-system planners who work on dementia.
JALR publishes research that explains, detects, treats and supports people living with Alzheimer’s disease and related dementias. The journal follows the disease continuum: the mechanisms that drive it, the methods that detect it, the treatments that act on it and the care that sustains patients and families.
Its aims are to publish methodologically sound research across that continuum, to connect laboratory findings with clinical and care questions, and to make the results freely available to everyone who can use them.
Interdisciplinary work is welcome, including collaborations among neurology, geriatrics, psychiatry, psychology, nursing, genetics, imaging, pharmacology, health economics and public health. The Aims and Scope page describes the four areas of the continuum in full.
Across the disease continuum
- 01
Mechanisms
How Alzheimer’s disease and related dementias arise and progress.
- Molecular and cellular pathophysiology
- Genetics and risk
- Neuroinflammation
- Cellular and animal models
- 02
Detection
How the disease is recognized, measured and predicted.
- Biomarkers
- Neuroimaging
- Cognitive assessment
- Risk prediction
- 03
Treatment
How the disease is treated and how treatments are evaluated.
- Clinical trials
- Drug discovery
- Therapeutic development
- Disease-modifying approaches
- 04
Care
How people living with dementia and their families are supported.
- Caregiver outcomes
- Quality of life
- Non-drug interventions
- Digital health and AI in care
Topics are illustrative and do not form a closed list.
What the journal publishes
One list applies across the journal website.
- Original Research (including clinical trials)
- Systematic Review and Meta-Analysis
- Review
- Mini-Review
- Methods and Protocols
- Short Communication
- Data Note
- Case Report
- Perspective
- Commentary
- Editorial
- Letter to the Editor
Preparation guidance for each type is in the Instructions for Authors.
How JALR publishes
- Access and license
- Every article is open access under CC BY 4.0. Authors retain copyright.
- Peer review
- Single-blind by default; double-blind review is available on request. Manuscripts that proceed to external peer review are normally evaluated by at least two independent subject-matter experts. See the Editorial Policies.
- Decisions
- Editorial decisions are based on scope, scientific quality, methodological rigor, ethical compliance, reporting quality, and relevance to the journal.
- Article processing charge
- USD 1,200, payable only after acceptance; withdrawal after submission is subject to the journal's withdrawal policy. See Article Processing Charges.
- Identifiers
- ISSN 2998-4211. Articles receive a Crossref DOI.
- Integrity
- Submissions are screened with Crossref Similarity Check, powered by iThenticate.
Editor-in-Chief
Saktimayee Roy
Research Associate Professor, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
Dr. Roy leads the journal with its Editorial Board. Members, affiliations and profiles are listed on the Editorial Board page.
Choose a submission route
JALR welcomes submissions throughout the year.
ManuscriptZone
The primary route. Create an account, submit the manuscript and follow its progress online.
Open ManuscriptZoneSimple manuscript submission form
The alternative route, with JALR preselected as the journal.
Open the formEditorial office email
The assisted route, for authors who need help to submit.
info@openaccesspub.org
Authors must use only one submission route for the same manuscript.